Skip to main content
All lobbying filings

TODD STRATEGY GROUP

Lobbying for FERRING PHARMACEUTICALS INC. · Biopharmaceutical company.

 Filing 4th Quarter - Termination
4th Quarter (Oct 1 - Dec 31) 2025 · New Jersey · House · Senate · $50,000.00 income · posted Apr 20, 2026

Official filing document

 Lobbying activity 1
Health Issues

Issues pertaining to reproductive health and access and coverage of infertility treatments and care. Issues related to infectious disease and hospital acquired infections.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem